MENU

NWBO Northwest Biotherapeutics, Inc. Chart, History Price & Graph

a developer of immunotherapy products

Industry: #Biotechnology
NWBO
Daily Signal:
Gain/Loss:
A.I.Advisor
published price charts
Last 5 trading days

Northwest Biotherapeutics, Inc. (NWBO) Price Chart Analysis: Trend, Key Levels, and Technical Signals

Key Takeaways

  • NWBO remains in a downtrend, with shares trading below key longer-term moving averages like the 50-day simple moving average near 0.22 and 200-day at 0.24.
  • Short-term moving averages signal buy, with 10 out of 12 MAs indicating buy, contrasting longer-term sell signals.
  • Momentum indicators are mixed: RSI(14) at 52.9 (neutral), Stochastic oversold at 39.7, and Williams %R deeply oversold at -85.4.
  • Pivot points highlight immediate support at 0.198 (S1) and resistance at 0.200 (R1), with the 52-week low near 0.19 under pressure.
  • Overall technical summary is neutral, with recent price action showing a 4% monthly decline amid elevated volume.

Trend Analysis

The price chart of NWBO reflects a persistent downtrend over the past year, with shares down approximately 41% amid broader biotech sector pressures. Over the last 30 days, the stock has declined about 8%, consolidating near multi-month lows around 0.19-0.20. Recent sessions show choppy price action, with intraday swings testing the 0.19 support zone. The stock recently passed below its 200-day moving average, confirming bearish momentum. Trading volume has spiked on down days, averaging over 2.5 million shares recently, indicating heightened selling interest.

Support and Resistance Levels

Key support levels cluster near recent lows: S1 at 0.198, S2 at 0.197, and S3 at 0.196 based on classic pivot points. The psychological 0.19 level aligns with the 52-week low, acting as a critical demand zone. Resistance begins at R1 0.200, followed by R2 0.201 and the 200-day MA near 0.203-0.205. A sustained break above 0.20 could target the 50-day MA around 0.21-0.22, while failure here reinforces the downtrend.

Moving Averages

Short-term moving averages are supportive, with the 5-day simple MA at 0.199 (buy) and 20-day at 0.199 (buy). However, the 50-day simple MA at 0.197-0.22 and 200-day at 0.203-0.24 generate sell signals as price trades below them. This divergence suggests potential short-term stabilization but longer-term bearish bias, with 10 buy and 2 sell signals overall from MAs.

Momentum Indicators

RSI(14) stands at 52.9, in neutral territory after easing from oversold levels. Stochastic (9,6) at 39.7 signals sell, while STOCHRSI(14) at 24.8 and Williams %R at -85.4 indicate oversold conditions that could precede a bounce. MACD(12,26) is flat at 0 (neutral), with ADX(14) at 49.6 signaling a strong trend—currently downward. These mixed readings point to weakening downside momentum but no clear reversal yet.

Volume and Market Activity

Trading volume has been above average, with recent sessions exceeding 2-5 million shares, particularly on declines. This suggests distribution rather than accumulation, though oversold indicators may draw dip-buyers. No major volume spikes accompany breakouts, reinforcing range-bound behavior near 0.19-0.20.

Tickeron’s AI Daily Buy/Sell Signals

Tickeron’s AI Daily Buy/Sell Signals leverage artificial intelligence to scrutinize vast datasets including technical indicators, price patterns, and historical trends for NWBO. These signals identify potential buy or sell opportunities by recognizing recurring market behaviors and momentum shifts. Traders rely on them to pinpoint entry/exit points, validate trend strength, and enhance decision-making in volatile environments like biotech stocks. Updated daily, they provide an objective layer to traditional chart analysis. Explore the signals to see the latest for NWBO.

Technical Outlook and Key Levels to Watch

Traders will monitor for a decisive move above 0.200 resistance or breakdown below 0.196 support, which could dictate next directional bias. Watch RSI for divergence from oversold levels and MACD for bullish crossover. The 50-day MA at 0.21 serves as a pivotal trendline, while volume confirmation remains essential amid ongoing consolidation.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full Disclaimers and Limitations.

View a ticker or compare two or three
NWBO
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
Northwest Biotherapeutics, Inc. (NWBO) Price Chart Analysis: Trend, Key Levels, and Technical Signals